Clinical Trial

Mental Health and Suicidality in Glioblastoma Patients in Germany

Name: Mental Health and Suicidality in Glioblastoma Patients in Germany — clinical trial record (NCT07409584)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SHINE-GLIO

Recruiting

View on ClinicalTrials.gov →

Summary

The aim of the study is to use standardized questionnaires to systematically record influencing factors or predictors for suicidal behavior in glioblastoma patients, particularly with regard to existing depression and anxiety symptoms.

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-07

Trial Details

NCT Number	NCT07409584
Lead Sponsor	University Hospital, Essen Collaborators: University Hospital Muenster, Charite University, Berlin, Germany, University Hospital Heidelberg, Neurological Clinic, Knappschaftskrankenhaus Bochum-Langendreer, Bochum, Germany, Universitätsklinikum Hamburg-Eppendorf
Conditions	Glioblastoma (GBM)
Enrollment	176 participants
Start Date	2026-03-18
Primary Completion	2027-02-28 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-18